Curcumol improves cisplatin sensitivity of human gastric cancer cells through inhibiting PI3K/AKT pathway

Abstract

Background: Curcumol was presented to unleash antitumor effects in a variety of cancers, including gastric cancer. However, the relevance between curcumol and cisplatin resistance in gastric cancer still remains unclear. Therefore, the current research was performed to survey the role of curcumol in cisplatin sensitivity in gastric cancer. Methods: First, BGC-823 and BGC-823/DDP cells were incubated with cisplatin for 48 hr and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) analysis was applied to determine the inhibition rate of cell proliferation and the halfmaximal inhibitory concentration (IC 50) of cisplatin. In addition, BGC-823 and BGC-823/DDP cells were treated with curcumol for 48 hr followed with detection of cell viability and apoptosis using MTT and flow cytometry assay, respectively. Moreover, MTT analysis was applied to test the effects of curcumol on cisplatin sensitivity in gastric cancer cells. Lastly, Western blot assay and qRT-PCR analysis were utilized to check the functions of curcumol on PI3K/AKT pathway-related markers. Results: We found that BGC-823/DDP cells exhibited stronger resistance to cisplatin compared with BGC-823 cells. Furthermore, curcumol evidently reduced cell proliferation and facilitated cell apoptosis in BGC-823/DDP and BGC-823 cells. Moreover, results from MTT assay demonstrated that curcumol notably promoted the suppression effect of cisplatin and decreased the IC 50 of cisplatin in BGC-823/DDP and BGC-823 cells. It was also presented that curcumol suppressed the PI3K/AKT pathway dose-dependently in BGC-823/DDP and BGC-823 cells. Conclusion: The findings in the current research demonstrated that curcumol could promote the sensitivity of gastric cancer cells to cisplatin-based chemotherapies via inhibiting the phosphatidylinositol 3-kinase (PI3K)/Protein Kinase B (AKT) pathway.

Transcriptomic Analysis of the Mechanisms for Alleviating Psoriatic Dermatitis Using Taodan Granules in an Imiquimod-Induced Psoriasis-like Mouse Model

“…( Lei et al, 2019 ). Multiple studies have shown that curcumin can inhibit cell proliferation and migration in numerous proliferative diseases ( Hashem et al, 2020 ; Huang et al, 2020 ; Li et al, 2020 ). In summary, we chose tanshinone IIA and curcumol to preliminarily establish quality control ( Figure 1 ).…”

Curcumol Targeting PAX8 Inhibits Ovarian Cancer Cell Migration and Invasion and Increases Chemotherapy Sensitivity of Niraparib

“…Studies have shown that Curcumol can affect cell membrane potential by killing tumor cells, inducing apoptosis and differentiation of tumor cells [ 8 , 9 ]. Curcumol plays an anti-tumor role by inhibiting tumor nuclear metabolism, angiogenesis and anti-mutation [ 10 ]. It can inhibit the proliferation of cervical cancer, ovarian cancer, gastric cancer and nasopharyngeal cancer cells.…”

Impact of Amarogentin on Gastric Carcinoma Cell Multiplication, Apoptosis and Migration via circKIF4A/miR-152-3p

“…Previous studies have demonstrated the long-term use of Chinese traditional herbal medicines in treating malignant diseases [ 6 , 7 ]. The active ingredients extracted from natural plants have anti-GC actions and can slow down GC progression [ 8 , 9 ]. Amarogentin (AG), first reported to exert anticarcinogenic action against cutaneous carcinoma via inducing cancer cell apoptosis, is the main active component isolated from Swertiamarin, which has been shown to promote liver cancer cell apoptosis and play an anti-liver cancer part [ 10 – 12 ].…”